Status:
TERMINATED
Assessment of Cardiovascular Risk Markers in Growth Hormone Deficient Patients With Nonsecreting Pituitary Adenomas
Lead Sponsor:
Columbia University
Collaborating Sponsors:
EMD Serono
Genentech, Inc.
Conditions:
Growth Hormone Deficiency
Pituitary Tumor
Eligibility:
All Genders
18-75 years
Brief Summary
The purpose of this study is to determine if patients with a history of nonsecreting pituitary adenomas with untreated GH deficient patients have profiles consistent with increased cardiovascular risk c...
Detailed Description
PROJECT TITLE: Assessment of Cardiovascular Risk in Patients with Growth Hormone Deficiency Following Transsphenoidal Surgery for Nonsecreting Pituitary Adenomas. BACKGROUND Recently, an awareness of...
Eligibility Criteria
Inclusion
- Adult patients with a history of a nonsecreting pituitary tumor with or without prior pituitary surgery.
Exclusion
- Current use of GH therapy or within the prior 3 months. Pituitary tumor necessitating surgery.
Key Trial Info
Start Date :
March 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2010
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00646308
Start Date
March 1 2008
End Date
March 1 2010
Last Update
April 26 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University Neuroendocrine Unit
New York, New York, United States, 10032